R2

The invisible heart disease crisis: Why congenital heart disease is moving up the global health agenda

Cancer Sequencing Becomes the Operating System of Precision Oncology

A new Lp(a) threshold could reshape cardiovascular risk assessment

The next cardiometabolic battleground is ultra-processed food

The ASCO Drug Race Still Runs Through Genomic Testing

High-Risk Prostate Cancer Moves Before the Metastatic Clock Starts

Servier’s $2.65B Muscular Dystrophy Deal Turns Rare Neurology Into a Commercial Priority

Lenacapavir Turns HIV Prevention Into an Access Stress Test

The Air We Breathe May Be Shaping the Future Burden of Blindness
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
